Multisystemic BCGitis: A rare complication of intravesical BCG immunotherapy for bladder cancer

Multisystemic BCGitis: A rare complication of intravesical BCG immunotherapy for bladder cancer

ABSTRACT: Intermediate- to high-grade non-muscle invasive bladder cancer is preferably treated with transurethral resection followed by adjuvant intravesical immunotherapy with Bacillus Calmette-Guérin (BCG). BCG acts as an immune stimulator, inducing a complex inflammatory response that selectively...

Full description

Bibliographic Details
Main Authors: Ana T. Vilares, MD, Cláudio Nunes Silva, MD, Miguel Correia da Silva, MD, Joel Sousa, MD, Bárbara Viamonte, MD, António J. Madureira, MD
Format: Article
Language:English
Published: Elsevier 2022-07-01
Series:Radiology Case Reports
Subjects:
Bladder cancer
Intravesical BCG immunotherapy
Treatment complications
Mycotic aortic pseudoaneurysm
Pulmonary mycobateriosis
Online Access:http://www.sciencedirect.com/science/article/pii/S1930043322003107

Internet

http://www.sciencedirect.com/science/article/pii/S1930043322003107

Similar Items